{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:45:48Z","timestamp":1789004748875,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS077946"],"award-info":[{"award-number":["R01NS077946"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS040068"],"award-info":[{"award-number":["R01NS040068"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000433"],"award-info":[{"award-number":["UL1TR000433"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Center for Inherited Disease Research"],"award-info":[{"award-number":["Center for Inherited Disease Research"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00415-018-8852-5","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T09:02:13Z","timestamp":1524474133000},"page":"1443-1453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Agreement between clinician-rated versus patient-reported outcomes in Huntington disease"],"prefix":"10.1007","volume":"265","author":[{"given":"Noelle E.","family":"Carlozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin L.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Nance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Dayalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"issue":"1","key":"8852_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5(1):40","journal-title":"Orphanet J Rare Dis"},{"key":"8852_CR2","doi-asserted-by":"publisher","unstructured":"Paulsen JS (2010) Early detection of Huntington disease. Future Neurol 5(1). \n                    https:\/\/doi.org\/10.2217\/fnl.09.78","DOI":"10.2217\/fnl.09.78"},{"issue":"5","key":"8852_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00005792-199709000-00001","volume":"76","author":"CA Ross","year":"1997","unstructured":"Ross CA et al (1997) Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltim) 76(5):305\u2013338","journal-title":"Medicine (Baltim)"},{"issue":"9557","key":"8852_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369(9557):218\u2013228","journal-title":"Lancet"},{"issue":"1","key":"8852_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ et al (2012) Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24\u00a0month observational data. Lancet Neurol 11(1):42\u201353","journal-title":"Lancet Neurol"},{"issue":"7, Suppl. 5","key":"8852_CR6","first-page":"A204","volume":"62","author":"SA Frank","year":"2004","unstructured":"Frank SA et al (2004) Functional decline due to chorea in Huntington\u2019s disease. Neurology 62(7, Suppl. 5):A204","journal-title":"Neurology"},{"issue":"3","key":"8852_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/mds.1097","volume":"16","author":"JP van Vugt","year":"2001","unstructured":"van Vugt JP et al (2001) Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington\u2019s disease. Mov Disord 16(3):481\u2013488","journal-title":"Mov Disord"},{"key":"8852_CR8","doi-asserted-by":"publisher","unstructured":"Mestre T et al (2009) Therapeutic interventions for symptomatic treatment in Huntington\u2019s disease. Cochrane Database Syst Rev (3):CD006456. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006456.pub2","DOI":"10.1002\/14651858.CD006456.pub2"},{"issue":"6","key":"8852_CR9","first-page":"1","volume":"15","author":"MR Van Walsem","year":"2017","unstructured":"Van Walsem MR et al (2017) Health-related quality of life and unmet healthcare needs in Huntington\u2019s disease. Health Qual Life Outcomes 15(6):1\u201310","journal-title":"Health Qual Life Outcomes"},{"issue":"15","key":"8852_CR10","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/mds.23337","volume":"25","author":"JS Paulsen","year":"2010","unstructured":"Paulsen JS et al (2010) Challenges assessing clinical endpoints in early Huntington disease. Mov Disord 25(15):2595\u20132603","journal-title":"Mov Disord"},{"issue":"2","key":"8852_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov Disord 11(2):136\u2013142","journal-title":"Mov Disord"},{"issue":"4","key":"8852_CR12","first-page":"217","volume":"21","author":"J Klempir","year":"2006","unstructured":"Klempir J et al (2006) Unified Huntington\u2019s disease rating scale: clinical practice and a critical approach. Funct Neurol 21(4):217\u2013221","journal-title":"Funct Neurol"},{"issue":"3","key":"8852_CR13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","volume":"57","author":"Huntington Study Group","year":"2001","unstructured":"Huntington Study Group (2001) A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology 57(3):397\u2013404","journal-title":"Neurology"},{"issue":"3","key":"8852_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","volume":"66","author":"Huntington Study Group","year":"2006","unstructured":"Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease. Neurology 66(3):366\u2013372","journal-title":"Neurology"},{"key":"8852_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ana.21181","volume":"62","author":"B Landwehrmeyer","year":"2007","unstructured":"Landwehrmeyer B et al (2007) Riluzole in Huntington\u2019s disease: a 3-year, randomized controlled study. Ann Neurol 62:262\u2013272","journal-title":"Ann Neurol"},{"key":"8852_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00336297.2001.10491746","volume":"53","author":"R Dishman","year":"2001","unstructured":"Dishman R, Washburn R, Schoeller D (2001) Measurement of physical activity. QUEST 53:295\u2013309","journal-title":"QUEST"},{"key":"8852_CR17","first-page":"224","volume-title":"Handbook of research methods in personality psychology","author":"DL Paulhus","year":"2007","unstructured":"Paulhus DL, Vazire S (2007) The self-report method. In: Robins RW, Fraley RC, Krueger RF (eds.) Handbook of research methods in personality psychology. Guilford Press, New York, NY, US, pp 224\u2013239"},{"issue":"2 Suppl 3","key":"8852_CR18","first-page":"73","volume":"22","author":"DF Cella","year":"1995","unstructured":"Cella DF (1995) Measuring quality of life in palliative care. Semin Oncol 22(2 Suppl 3):73\u201381","journal-title":"Semin Oncol"},{"key":"8852_CR19","unstructured":"World Health Organization (1946) Preamble to the Constitution of WHO as adopted by the International Health Conference, New York, 19 June\u201322 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of WHO, no. 2, p. 100) and entered into force on 7 April 1948"},{"key":"8852_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"US Department of Health and Human Services: Food and Drug Administration","year":"2006","unstructured":"US Department of Health and Human Services: Food and Drug Administration (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"8852_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/1359105312438109","volume":"18","author":"NE Carlozzi","year":"2013","unstructured":"Carlozzi NE, Tulsky DS (2013) Identification of health-related quality of life (HRQOL) issues relevant to individuals with HD. J Health Psychol 18(2):212\u2013225","journal-title":"J Health Psychol"},{"issue":"7","key":"8852_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","volume":"83","author":"JC Stout","year":"2012","unstructured":"Stout JC et al (2012) Evaluation of longitudinal 12 and 24\u00a0month cognitive outcomes in premanifest and early Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 83(7):687\u2013694","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"8852_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0020937","volume":"25","author":"JC Stout","year":"2011","unstructured":"Stout JC et al (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25(1):1\u201314","journal-title":"Neuropsychology"},{"issue":"9","key":"8852_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ et al (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791\u2013801","journal-title":"Lancet Neurol"},{"issue":"1","key":"8852_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ et al (2011) Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10(1):31\u201342","journal-title":"Lancet Neurol"},{"issue":"4","key":"8852_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/13803390600718958","volume":"29","author":"KF Hoth","year":"2007","unstructured":"Hoth KF et al (2007) Patients with Huntington\u2019s disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol 29(4):365\u2013376","journal-title":"J Clin Exp Neuropsychol"},{"issue":"4","key":"8852_CR27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5114\/ninp.2012.30262","volume":"46","author":"EJ Sitek","year":"2012","unstructured":"Sitek EJ et al (2012) Poor insight into memory impairment in patients with Huntington disease. Neurol Neurochir Pol 46(4):318\u2013325","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"8852_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/pcn.12006","volume":"67","author":"EJ Sitek","year":"2013","unstructured":"Sitek EJ et al (2013) Self-awareness of executive dysfunction in Huntington\u2019s disease: comparison with Parkinson\u2019s disease and cervical dystonia. Psychiatry Clin Neurosci 67(1):59\u201362","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"8852_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1017\/S1355617711000725","volume":"17","author":"EJ Sitek","year":"2011","unstructured":"Sitek EJ et al (2011) Self-awareness of motor dysfunction in patients with Huntington\u2019s disease in comparison to Parkinson\u2019s disease and cervical dystonia. J Int Neuropsychol Soc 17(5):788\u2013795","journal-title":"J Int Neuropsychol Soc"},{"issue":"6","key":"8852_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/archneur.55.6.801","volume":"55","author":"JS Snowden","year":"1998","unstructured":"Snowden JS et al (1998) Awareness of involuntary movements in Huntington disease. Arch Neurol 55(6):801\u2013805","journal-title":"Arch Neurol"},{"issue":"1","key":"8852_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s100720170066","volume":"22","author":"C Vitale","year":"2001","unstructured":"Vitale C et al (2001) Unawareness of dyskinesias in Parkinson\u2019s and Huntington\u2019s diseases. Neurol Sci 22(1):105\u2013106","journal-title":"Neurol Sci"},{"issue":"4","key":"8852_CR32","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.comppsych.2013.12.019","volume":"55","author":"AL Stuart","year":"2014","unstructured":"Stuart AL et al (2014) Comparison of self-report and structured clinical interview in the identification of depression. Compr Psychiatry 55(4):866\u2013869","journal-title":"Compr Psychiatry"},{"issue":"9","key":"8852_CR33","doi-asserted-by":"publisher","first-page":"e00365","DOI":"10.1002\/brb3.365","volume":"5","author":"A Fischer","year":"2015","unstructured":"Fischer A et al (2015) Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. Brain Behav 5(9):e00365","journal-title":"Brain Behav"},{"issue":"9","key":"8852_CR34","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/PSY.0000000000000530","volume":"79","author":"JAC Laferton","year":"2017","unstructured":"Laferton JAC et al (2017) Screening for DSM-5 somatic symptom disorder: diagnostic accuracy of self-report measures within a population sample. Psychosom Med 79(9):974\u2013981","journal-title":"Psychosom Med"},{"issue":"5","key":"8852_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/EDE.0000000000000695","volume":"28","author":"SN Hinkle","year":"2017","unstructured":"Hinkle SN et al (2017) Validation of self-reported diagnosis of gestational diabetes at 6-weeks postpartum. Epidemiology 28(5):747\u2013752","journal-title":"Epidemiology"},{"key":"8852_CR36","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2017.0082","author":"MJ Silverstein","year":"2017","unstructured":"Silverstein MJ et al (2017) How informative are self-reported adult attention-deficit\/hyperactivity disorder symptoms? An examination of the agreement between the adult attention-deficit\/hyperactivity disorder self-report scale V1.1 and adult attention-deficit\/hyperactivity disorder investigator symptom rating scale. J Child Adolesc Psychopharmacol. \n                    https:\/\/doi.org\/10.1089\/cap.2017.0082","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"8852_CR37","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3899\/jrheum.161396","volume":"44","author":"V Videm","year":"2017","unstructured":"Videm V et al (2017) Self-reported diagnosis of rheumatoid arthritis or ankylosing spondylitis has low accuracy: data from the Nord-Trondelag health study. J Rheumatol 44(8):1134\u20131141","journal-title":"J Rheumatol"},{"issue":"2","key":"8852_CR38","first-page":"184","volume":"32","author":"AC Russo","year":"2017","unstructured":"Russo AC, Fingerhut EC (2017) Consistency of self-reported neurocognitive symptoms, post-traumatic stress disorder symptoms, and concussive events from end of first deployment to Veteran Health Administration Comprehensive Traumatic Brain Injury Evaluation by Operations Enduring Freedom\/Iraqi Freedom\/New Dawn Veterans. Arch Clin Neuropsychol 32(2):184\u2013197","journal-title":"Arch Clin Neuropsychol"},{"issue":"5","key":"8852_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1023\/A:1025766713188","volume":"16","author":"JC DeViva","year":"2003","unstructured":"DeViva JC, Bloem WD (2003) Symptom exaggeration and compensation seeking among combat veterans with posttraumatic stress disorder. J Trauma Stress 16(5):503\u2013507","journal-title":"J Trauma Stress"},{"issue":"5","key":"8852_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1017\/S1092852900017843","volume":"7","author":"ML Rohling","year":"2002","unstructured":"Rohling ML, Allen LM, Green P (2002) Who is exaggerating cognitive impairment and who is not? CNS Spectr 7(5):387\u2013395","journal-title":"CNS Spectr"},{"issue":"2","key":"8852_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/pon.3409","volume":"23","author":"AM Krebber","year":"2014","unstructured":"Krebber AM et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 23(2):121\u2013130","journal-title":"Psychooncology"},{"key":"8852_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13584-016-0111-6","volume":"5","author":"R Hamood","year":"2016","unstructured":"Hamood R et al (2016) A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors. Isr J Health Policy Res 5:50","journal-title":"Isr J Health Policy Res"},{"issue":"1","key":"8852_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12891-016-1349-4","volume":"17","author":"T Lo","year":"2016","unstructured":"Lo T et al (2016) Discordance between self-reported arthritis and musculoskeletal signs and symptoms in older women. BMC Musculoskelet Disord 17(1):494","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"8852_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/HTR.0000000000000225","volume":"31","author":"S Nazem","year":"2016","unstructured":"Nazem S et al (2016) Actigraphic and sleep diary measures in Veterans with traumatic brain injury: discrepancy in selected sleep parameters. J Head Trauma Rehabil 31(2):136\u2013146","journal-title":"J Head Trauma Rehabil"},{"key":"8852_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12884-016-0905-0","volume":"16","author":"JPR McIntyre","year":"2016","unstructured":"McIntyre JPR et al (2016) A description of sleep behaviour in healthy late pregnancy, and the accuracy of self-reports. BMC Pregnancy Childbirth 16:115. \n                    https:\/\/doi.org\/10.1186\/s12884-016-0905-0","journal-title":"BMC Pregnancy Childbirth"},{"issue":"8","key":"8852_CR46","doi-asserted-by":"publisher","first-page":"e0182718","DOI":"10.1371\/journal.pone.0182718","volume":"12","author":"SY Kim","year":"2017","unstructured":"Kim SY et al (2017) Discrepancy between self-assessed hearing status and measured audiometric evaluation. Plos One 12(8):e0182718","journal-title":"Plos One"},{"key":"8852_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.clinpsy.3.022806.091415","volume":"4","author":"S Shiffman","year":"2008","unstructured":"Shiffman S, Stone AA, Hufford MR (2008) Ecological momentary assessment. Annu Rev Clin Psychol 4:1\u201332","journal-title":"Annu Rev Clin Psychol"},{"issue":"5","key":"8852_CR48","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/YCO.0000000000000267","volume":"29","author":"O Van den Bergh","year":"2016","unstructured":"Van den Bergh O, Walentynowicz M (2016) Accuracy and bias in retrospective symptom reporting. Curr Opin Psychiatry 29(5):302\u2013308","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"8852_CR49","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1212\/WNL.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder K et al (2000) Rate of functional decline in Huntington\u2019s disease. Neurology 54(2):452","journal-title":"Neurology"},{"issue":"10","key":"8852_CR50","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1007\/s11136-016-1386-3","volume":"25","author":"NE Carlozzi","year":"2016","unstructured":"Carlozzi NE et al (2016) HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD). Qual Life Res 25(10):2441\u20132455","journal-title":"Qual Life Res"},{"key":"8852_CR51","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jbi.2015.05.003","volume":"55","author":"DA Hanauer","year":"2015","unstructured":"Hanauer DA et al (2015) Supporting information retrieval from electronic health records: a report of University of Michigan\u2019s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). J Biomed Inform 55:290\u2013300","journal-title":"J Biomed Inform"},{"issue":"6","key":"8852_CR52","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/archneur.63.6.883","volume":"63","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS et al (2006) Preparing for preventive clinical trials\u2014the Predict-HD study. Arch Neurol 63(6):883\u2013890","journal-title":"Arch Neurol"},{"issue":"7","key":"8852_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ajmg.b.31232","volume":"156","author":"Y Zhang","year":"2011","unstructured":"Zhang Y et al (2011) Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156(7):751\u2013763","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"8852_CR54","volume-title":"SAS 9.4 language reference concepts","author":"SAS Institute","year":"2013","unstructured":"SAS Institute (2013) SAS 9.4 language reference concepts. SAS Institute, Cary"},{"key":"8852_CR55","unstructured":"SPSS Inc (2013) IBM SPSS statistics for windows. Released 2013. IBM Corp., Armonk"},{"key":"8852_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02310555","volume":"16","author":"LG Cronbach","year":"1951","unstructured":"Cronbach LG (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297\u2013334","journal-title":"Psychometrika"},{"key":"8852_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF02293600","volume":"49","author":"LS Feldt","year":"1980","unstructured":"Feldt LS (1980) A test of hypothesis that Cronbach\u2019s alpha coefficient is the same for two tests administered to the same sample. Psychometrika 49:99\u2013105","journal-title":"Psychometrika"},{"issue":"293","key":"8852_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/01621459.1961.10482090","volume":"56","author":"OJ Dunn","year":"1961","unstructured":"Dunn OJ (1961) Multiple comparisons among means. J Am Stat Assoc 56(293):52\u201364","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"8852_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):10","journal-title":"Educ Psychol Meas"},{"issue":"3","key":"8852_CR60","first-page":"7","volume":"22","author":"M McHugh","year":"2012","unstructured":"McHugh M (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):7","journal-title":"Biochem Med"},{"key":"8852_CR61","volume-title":"Psychometric theory","author":"J Nunnally","year":"1994","unstructured":"Nunnally J, Bernstein I (1994) Psychometric theory. McGraw-Hill, New York"},{"issue":"2","key":"8852_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JHD-170245","volume":"6","author":"AM Travessa","year":"2017","unstructured":"Travessa AM et al (2017) Fifteen years of clinical trials in Huntington\u2019s disease: a very low clinical drug development success rate. J Huntingt Dis 6(2):157\u2013163","journal-title":"J Huntingt Dis"},{"key":"8852_CR63","doi-asserted-by":"publisher","unstructured":"Mestre T et al (2009) Therapeutic interventions for disease progression in Huntington\u2019s disease. Cochrane Database Syst Rev 8(3):CD006455. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006455.pub2","DOI":"10.1002\/14651858.CD006455.pub2"},{"issue":"4","key":"8852_CR64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/arclin\/11.4.295","volume":"11","author":"AW Deckel","year":"1996","unstructured":"Deckel AW, Morrison D (1996) Evidence of a neurologically based \u201cdenial of illness\u201d in patients with Huntington\u2019s disease. Arch Clin Neuropsychol 11(4):295\u2013302","journal-title":"Arch Clin Neuropsychol"},{"issue":"13","key":"8852_CR65","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1212\/WNL.0b013e3182a55f05","volume":"81","author":"EA McCusker","year":"2013","unstructured":"McCusker EA et al (2013) Unawareness of motor phenoconversion in Huntington disease. Neurology 81(13):1141\u20131147","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8852-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:02:46Z","timestamp":1589634166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8852-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["8852"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8852-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"20 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N. E. Carlozzi currently has research grants from the NIH; she is also supported by grant funding from the NIH and CHDI. She provides patient-reported outcome measurement selection and application consultation for Teva Pharmaceuticals. She declares no conflicts of interest. N. R. Boileau is supported by grant funding from the NIH; he declares no conflicts of interest. J. S. Perlmutter currently has research funding from the NIH, HDSA, CHDI, Michael J Fox Foundation, Barnes Jewish Hospital Foundation, the Lauren and Lee Fixel Family Foundation, and the APDA. He has received honoraria from the University of Rochester, American Academy of Neurology, Movement Disorders Society, Toronto Western Hospital, Alberta Innovates, Parkinson Disease Foundation, Columbia University, St. Louis University, Harvard University, University of Michigan, Huntington Study Group, Stanford University, University of Florida at Gainesville, and World Parkinson Congress. He declares no conflicts of interest. K. Chou currently has funding from the NIH and Cavion, receives royalties from UpToDate, Springer Publishing and Demos Health and serves as a consultant for Accordant and Sunovion Pharmaceuticals. He declares no conflicts of interest. J. C. Stout has received research funding in the past 3\u00a0years from the Australian National Health and Medical Research Council, University College London, the CHDI Foundation, Prana Biotechnology, and the University of California, Davis. She is a Director of Stout Neuropsych Pty Ltd, which has received funding from Omeros, Teva Pharmaceuticals, Vaccinex, and Isis. She has been a consultant to Prana Biotechnology and Roche. She receives compensation as a member of the Board of the Huntington\u2019s Study Group. She declares no conflicts of interest. J. S. Paulsen currently has research grants from the NIH; she is also supported by grant funding from NIH, NINDS, and CHDI; she declares no conflicts of interest. M. K. McCormack currently has grants from the NJ Department of Health; he declares no conflicts of interest. D. Cella receives grant funding from the National Institutes of Health and reports that he has no conflicts of interest. M. A. Nance currently has funding from the NIH, HDSA, CHDI, and the Parkinson\u2019s Foundation. She has received research funding in the last 3\u00a0years from Teva Pharmaceuticals, Biotie, and Sunovion. She has received honoraria from WebMD, Worrell Inc, Optio Biopharma, and Augsburg College. She declares on conflicts of interest. J.-S. Lai currently has research grants from the NIH and Neurofibromatosis Therapeutic Acceleration Program at John Hopkins University; she declares no conflicts of interest. P. Dayalu currently has research grants from the NIH, Astra-Zeneca, and Vaccinex. He declares no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All data was collected in accordance with the local site institutional review boards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Participants provided informed consent prior to study participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}